{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T01:12:25Z","timestamp":1788484345960,"version":"build-2803163510"},"reference-count":194,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jchromb.2026.125260","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:04:22Z","timestamp":1787241862000},"page":"125260","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Analytical strategies for complex injectables: the expanding role of LC-MS technologies"],"prefix":"10.1016","volume":"1283","author":[{"given":"Niraj","family":"Shukla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Pawar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamta","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2026.125260_bb0005","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s13346-022-01223-5","article-title":"An expanding horizon of complex injectable products: development and regulatory considerations","volume":"13","author":"Panchal","year":"2023","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jchromb.2026.125260_bb0010","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s13346-020-00758-9","article-title":"An injectable microparticle formulation for the sustained release of the specific MEK inhibitor PD98059: in vitro evaluation and pharmacokinetics","volume":"11","author":"Naguib","year":"2021","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jchromb.2026.125260_bb0015","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1556\/1326.2023.01129","article-title":"Development and validation of an LC-MS\/MS method for the quantification of free and total doxorubicin in human plasma and its clinical application for a novel doxorubicin hydrochloride liposome injection in Chinese patients with breast cancer","volume":"36","author":"Zhang","year":"2024","journal-title":"Acta Chromatogr."},{"key":"10.1016\/j.jchromb.2026.125260_bb0020","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s00706-016-1773-z","article-title":"The use of HPLC-Q-TOF-MS for comprehensive screening of drugs and psychoactive substances in hair samples and several \u201clegal highs\u201d products","volume":"147","author":"Aszyk","year":"2016","journal-title":"Monatsh. Chem."},{"key":"10.1016\/j.jchromb.2026.125260_bb0025","series-title":"Complex injectables: development, delivery, and advancement, delivery of drugs: volume 2: expectations and realities of multifunctional drug delivery systems","first-page":"191","author":"Pandey","year":"2020"},{"key":"10.1016\/j.jchromb.2026.125260_bb0030","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1039\/D2LC00463A","article-title":"Liposome manufacturing under continuous flow conditions: towards a fully integrated set-up with in-line control of critical quality attributes","volume":"23","author":"Sheybanifard","year":"2023","journal-title":"Lab Chip"},{"key":"10.1016\/j.jchromb.2026.125260_bb0035","series-title":"FDA approves first generic of once-daily GLP-1 injection to lower blood sugar in patients with type 2 diabetes","author":"U.S. Food and Drug Administration","year":"2024"},{"key":"10.1016\/j.jchromb.2026.125260_bb0040","series-title":"Aripiprazole prolonged release suspension for injection (Abilify Maintena) (300 mg and 400 mg vial)","author":"Canadian Agency for Drugs and Technologies in Health","year":"2017"},{"key":"10.1016\/j.jchromb.2026.125260_bb0045","series-title":"Cipla receives final approval for the generic version of Somatuline\u00ae Depot (lanreotide) injection 120 mg\/ 0.5 mL, 90 mg\/0.3 mL, 60 mg\/0.2 mL","author":"Cipla","year":"2024"},{"key":"10.1016\/j.jchromb.2026.125260_bb0050","series-title":"Gland Pharma receives USFDA approval for Edaravone injection","author":"Express Pharma","year":"2024"},{"key":"10.1016\/j.jchromb.2026.125260_bb0055","series-title":"Bupivacaine liposomal injection (Exparel) for postsurgical analgesia in patient undergoing laparoscopic bariatric surgery","author":"The Cleveland Clinic","year":"2016"},{"key":"10.1016\/j.jchromb.2026.125260_bb0060","series-title":"HALAVEN\u00ae (eribulin mesylate) injection for the treatment of advanced liposarcoma","author":"Eisai Inc","year":"2025"},{"key":"10.1016\/j.jchromb.2026.125260_bb0065","series-title":"FDA approves pembrolizumab and berahyaluronidase Alfa-Pmph for subcutaneous injection","author":"U.S. Food and Drug Administration","year":"2025"},{"key":"10.1016\/j.jchromb.2026.125260_bb0070","series-title":"FDA grants accelerated approval to first treatment for Barth syndrome","author":"U.S. Food and Drug Administration","year":"2025"},{"key":"10.1016\/j.jchromb.2026.125260_bb0075","series-title":"FDA approves Merck\u2019s ENFLONSIA\u2122 (Clesrovimab-Cfor) for prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in infants born during or entering their first RSV season","author":"Merck","year":"2025"},{"key":"10.1016\/j.jchromb.2026.125260_bb0080","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/MS9.0000000000002848","article-title":"FDA approval of crovalimab: a milestone in paroxysmal nocturnal hemoglobinuria treatment","volume":"87","author":"Anwar","year":"2025","journal-title":"Ann. Med. Surg. (Lond.)"},{"key":"10.1016\/j.jchromb.2026.125260_bb0085","series-title":"FDA approves updated indication for WINREVAIR\u2122 (Sotatercept-Csrk) in adults with pulmonary arterial hypertension (PAH, WHO* group 1 pulmonary hypertension) based on phase 3 ZENITH study","author":"Merck","year":"2025"},{"key":"10.1016\/j.jchromb.2026.125260_bb0090","series-title":"Quality considerations for developing complex generics","author":"Subramanian","year":"2023"},{"key":"10.1016\/j.jchromb.2026.125260_bb0095","series-title":"International conference on harmonisation, stability testing of new drug substances and products Q1A(R2)","year":"2003"},{"key":"10.1016\/j.jchromb.2026.125260_bb0100","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.chroma.2007.10.111","article-title":"Performance evaluation of evaporative light scattering detection and charged aerosol detection in reversed phase liquid chromatography","volume":"1189","author":"Vervoort","year":"2008","journal-title":"J. Chromatogr. A"},{"issue":"4","key":"10.1016\/j.jchromb.2026.125260_bb0105","first-page":"8713","article-title":"Limitations and remedial approaches on analytical methods for selected classes of non-chromophore pharmaceuticals - A systematic review","volume":"11","author":"Yi","year":"2020","journal-title":"J. Global Trends Pharm. Sci."},{"key":"10.1016\/j.jchromb.2026.125260_bb0110","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/chromsci\/bmz021","article-title":"Determination of cholesterol and its derivatives in nanoliposomes as drug delivery conveyances by HPLC-UV: a simple, accurate and cost-effective method development and validation approach","volume":"57","author":"Beheshti","year":"2019","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.jchromb.2026.125260_bb0115","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jpba.2015.11.020","article-title":"A versatile, quantitative analytical method for pharmaceutical relevant lipids in drug delivery systems","volume":"119","author":"Jeschek","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2026.125260_bb0120","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1021\/acs.molpharmaceut.2c00021","article-title":"Simultaneous chromatographic quantitation of drug substance and excipients in nanoformulations using a combination of evaporative light scattering and absorbance detectors","volume":"19","author":"B\u00f6ttger","year":"2022","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jchromb.2026.125260_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.115011","article-title":"A rapid and quantitative reversed-phase HPLC-DAD\/ELSD method for lipids involved in nanoparticle formulations","volume":"220","author":"Mousli","year":"2022","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2026.125260_bb0130","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1208\/s12249-013-9967-8","article-title":"Simultaneous determination of polyethylene glycol-conjugated liposome components by using reversed-phase high-performance liquid chromatography with UV and evaporative light scattering detection","volume":"14","author":"Shibata","year":"2013","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jchromb.2026.125260_bb0135","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jpba.2018.11.048","article-title":"Ion quantification in liposomal drug products using high performance liquid chromatography","volume":"165","author":"Wu","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"2","key":"10.1016\/j.jchromb.2026.125260_bb0140","doi-asserted-by":"crossref","first-page":"421","DOI":"10.29228\/jrp.139","article-title":"RP-HPLC method development and validation for quantification of letrozole solid lipid nanoparticle","volume":"26","author":"Priyadarsini","year":"2022","journal-title":"J. Res. Pharm."},{"key":"10.1016\/j.jchromb.2026.125260_bb0145","article-title":"Validation of an HPLC-CAD method for determination of lipid content in LNP-encapsulated COVID-19 mRNA vaccines","volume":"11","author":"Yu","year":"2023","journal-title":"Vaccines (Basel)."},{"key":"10.1016\/j.jchromb.2026.125260_bb0150","doi-asserted-by":"crossref","first-page":"19637","DOI":"10.1021\/acsomega.4c01524","article-title":"A reliable quantification of cholesterol and 25-hydroxycholesterol in liposomal adjuvant formulation by liquid chromatography high-resolution tandem mass spectrometry","volume":"9","author":"Abucayon","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.jchromb.2026.125260_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics8030029","article-title":"Rapid quantification and validation of lipid concentrations within liposomes","volume":"8","author":"Roces","year":"2016","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jchromb.2026.125260_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/molecules30030486","article-title":"AQbD-based UPLC-ELSD method for quantifying medium chain triglycerides in Labrafac\u2122 WL 1349 for nanoemulsion applications","volume":"30","author":"Gaggero","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.jchromb.2026.125260_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/ph17091217","article-title":"RP-CAD for lipid quantification: systematic method development and intensified LNP process characterization","volume":"17","author":"Beckert","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jchromb.2026.125260_bb0170","article-title":"Overview of novel sample pretreatment methods and their pharmaceutical applications in bioanalysis","author":"Haneef","year":"2025","journal-title":"J. Appl. Pharm. Sci."},{"key":"10.1016\/j.jchromb.2026.125260_bb0175","doi-asserted-by":"crossref","first-page":"21016","DOI":"10.1021\/acsomega.3c01877","article-title":"A liquid chromatography high-resolution tandem mass spectrometry method to quantify QS-21 adjuvant and its degradation products in liposomal drug formulations","volume":"8","author":"Abucayon","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.jchromb.2026.125260_bb0180","first-page":"1053","article-title":"Sustainable liposomal delivery of Centella asiatica polyphenols: \u03b2-sitosterol stabilization, LC-MS\/MS profiling, and simulated release study, sustainable","volume":"3","author":"Tripathy","year":"2025","journal-title":"Food Technol."},{"key":"10.1016\/j.jchromb.2026.125260_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124164","article-title":"Excipient-related impurities in liposome drug products","volume":"657","author":"Wang","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jchromb.2026.125260_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.115114","article-title":"Development of a liquid chromatography-tandem mass spectrometry method for the analysis of docetaxel-loaded poly(lactic-co-glycolic acid) nanoparticles","volume":"223","author":"Khajavinia","year":"2023","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2026.125260_bb0195","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/978-1-0716-2954-3_20","article-title":"High-performance liquid chromatography coupled with tandem mass spectrometry method for the identification and quantification of lipids in liposomes","volume":"2622","author":"Shi","year":"2023","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jchromb.2026.125260_bb0200","doi-asserted-by":"crossref","DOI":"10.1002\/jssc.70152","article-title":"Development of a solid phase extraction cartridge-based analytical method for determination of free drug in nanoliposomal oncology drug formulations","volume":"48","author":"Zhang","year":"2025","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.jchromb.2026.125260_bb0205","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s13346-012-0064-4","article-title":"Drug release from nanomedicines: selection of appropriate encapsulation and release methodology","volume":"2","author":"Wallace","year":"2012","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jchromb.2026.125260_bb0210","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1111\/j.2042-7158.1996.tb03904.x","article-title":"Comparative study of separation of non-encapsulated drug from unilamellar liposomes by various methods","volume":"48","author":"Dipali","year":"1996","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jchromb.2026.125260_bb0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics12080732","article-title":"In vitro release study of the polymeric drug nanoparticles: development and validation of a novel method","volume":"12","author":"Weng","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jchromb.2026.125260_bb0220","doi-asserted-by":"crossref","DOI":"10.1021\/acschemneuro.2c00673","article-title":"Amoxapine-loaded solid lipid nanoparticles with superior preclinical pharmacokinetics for better brain delivery: LC-MS\/MS and GC-MS analysis","author":"Pawar","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.jchromb.2026.125260_bb0225","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jmsacl.2022.04.002","article-title":"Mitigating analyte to stable isotope labelled internal standard cross-signal contribution in quantitative liquid chromatography-tandem mass spectrometry","volume":"24","author":"Radovanovic","year":"2022","journal-title":"J. Mass Spect. Adv. Clin. Lab"},{"key":"10.1016\/j.jchromb.2026.125260_bb0230","doi-asserted-by":"crossref","DOI":"10.1002\/rcm.9377","article-title":"Use of in-sample calibration curve approach for quantification of peptides with high-resolution mass spectrometry","volume":"36","author":"Kandi","year":"2022","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.jchromb.2026.125260_bb0235","doi-asserted-by":"crossref","DOI":"10.3390\/molecules29102278","article-title":"Innovative solid-phase extraction strategies for improving the advanced chromatographic determination of drugs in challenging biological samples","volume":"29","author":"Mahdavijalal","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.jchromb.2026.125260_bb0240","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.4155\/bio.13.187","article-title":"Evaluation and subsequent minimization of matrix effects caused by phospholipids in LC\u2013MS analysis of biological samples","volume":"5","author":"Janusch","year":"2013","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jchromb.2026.125260_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.114639","article-title":"Incorporating protein precipitation to resolve hybrid IP-LC-MS assay interference for ultrasensitive quantification of intact therapeutic insulin dimer in human plasma","volume":"212","author":"Sun","year":"2022","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2026.125260_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2023.340973","article-title":"Development of polyanion-metal ion solution systems to overcome phospholipids-related matrix effects in LC-MS\/MS-based bioanalysis","volume":"1250","author":"Liu","year":"2023","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jchromb.2026.125260_bb0255","doi-asserted-by":"crossref","first-page":"6049","DOI":"10.1039\/D1AN01047F","article-title":"Overview, consequences, and strategies for overcoming matrix effects in LC-MS analysis: a critical review","volume":"146","author":"Nasiri","year":"2021","journal-title":"Analyst"},{"key":"10.1016\/j.jchromb.2026.125260_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113642","article-title":"Analytical characterization of liposomes and other lipid nanoparticles for drug delivery","volume":"192","author":"Fan","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2026.125260_bb0265","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.4155\/bio-2017-0214","article-title":"Matrix effects and application of matrix effect factor","volume":"9","author":"Zhou","year":"2017","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jchromb.2026.125260_bb0270","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jpba.2005.03.009","article-title":"Ion-suppression effects in liquid chromatography-tandem mass spectrometry due to a formulation agent, a case study in drug discovery bioanalysis","volume":"39","author":"Larger","year":"2005","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2026.125260_bb0275","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-26926-0","article-title":"A novel mechanism for the loss of mRNA activity in lipid nanoparticle delivery systems","volume":"12","author":"Packer","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jchromb.2026.125260_bb0280","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/rcm.2938","article-title":"Evaluating the utility of ion mobility separation in combination with high-pressure liquid chromatography\/mass spectrometry to facilitate detection of trace impurities in formulated drug products","volume":"21","author":"Eckers","year":"2007","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.jchromb.2026.125260_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2024.124005","article-title":"Monitoring stability indicating impurities and aldehyde content in lipid nanoparticle raw material and formulated drugs","volume":"1234","author":"Birdsall","year":"2024","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jchromb.2026.125260_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2025.114762","article-title":"Impurity profiling of PEGylated myristoyl diglyceride, DMG-PEG 2000, a functional excipient used in mRNA lipid nanoparticle formulations","volume":"214","author":"Sperber","year":"2025","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jchromb.2026.125260_bb0295","doi-asserted-by":"crossref","first-page":"631","DOI":"10.4155\/bio-2024-0047","article-title":"Assessment of matrix effect in quantitative LC-MS bioanalysis","volume":"16","author":"Fu","year":"2024","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jchromb.2026.125260_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2021.122512","article-title":"Evaluation of strategies for overcoming trifluoroacetic acid ionization suppression resulted in single-column intact level, middle-up, and bottom-up reversed-phase LC-MS analyses of antibody biopharmaceuticals","volume":"233","author":"Khalikova","year":"2021","journal-title":"Talanta"},{"key":"10.1016\/j.jchromb.2026.125260_bb0305","doi-asserted-by":"crossref","DOI":"10.3390\/molecules30173567","article-title":"Applications of hydrophilic interaction chromatography in pharmaceutical impurity profiling: a comprehensive review of two decades","volume":"30","author":"Ntorkou","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.jchromb.2026.125260_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2024.465524","article-title":"Applications of hydrophilic interaction and mixed-mode liquid chromatography in pharmaceutical analysis","volume":"1739","author":"Wei","year":"2025","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jchromb.2026.125260_bb0315","doi-asserted-by":"crossref","first-page":"10227","DOI":"10.1021\/acs.analchem.5c00011","article-title":"Two-step peptide solubilization increases coverage in high-sensitivity nano HILIC\/MS\/MS-based proteomics","volume":"97","author":"Akamatsu","year":"2025","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jchromb.2026.125260_bb0320","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jconrel.2019.03.002","article-title":"Complex sameness: separation of mixed poly(lactide-co-glycolide)s based on the lactide:glycolide ratio","volume":"300","author":"Skidmore","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jchromb.2026.125260_bb0325","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1021\/jasms.4c00447","article-title":"Size-exclusion chromatography-electrospray-ionization mass spectrometry to characterize end group and chemical distribution of poly(lactide-co-glycolide) copolymers","volume":"36","author":"Serizawa","year":"2025","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.jchromb.2026.125260_bb0330","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1021\/jasms.0c00137","article-title":"Mass spectrometry-based analytical strategy for comprehensive molecular characterization of biodegradable poly(lactic-co-glycolic acid) copolymers","volume":"31","author":"Fouquet","year":"2020","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.jchromb.2026.125260_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.114188","article-title":"Simultaneous characterization of insulin HMWP and protamine sulphate in complex formulations through SEC-coupled mass spectrometry","volume":"203","author":"Srivatsa","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2026.125260_bb0340","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1021\/acs.analchem.4c06084","article-title":"Coupling of size exclusion chromatography to high throughput charge detection mass spectrometry for the analysis of large proteins and virus-like particles","volume":"97","author":"Parikh","year":"2025","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jchromb.2026.125260_bb0345","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1021\/acs.analchem.4c06296","article-title":"High-throughput quantification and characterization of dual payload mRNA\/LNP cargo via deformulating size exclusion and ion pairing reversed phase assays","volume":"97","author":"Imio\u0142ek","year":"2025","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jchromb.2026.125260_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2026.345215","article-title":"Two-dimensional AEX \u2013 IP-RPLC: new insights on mRNA integrity and encapsulation efficiency of mRNA-lipid nanoparticle formulations","volume":"1394","author":"Aebischer","year":"2026","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jchromb.2026.125260_bb0355","doi-asserted-by":"crossref","first-page":"10298","DOI":"10.1021\/acsabm.5c01565","article-title":"Two-dimensional liquid chromatography method for assembly homogeneity analysis and mass spectrometric characterization of RNA nanoparticles","volume":"8","author":"Wu","year":"2025","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.jchromb.2026.125260_bb0360","doi-asserted-by":"crossref","first-page":"14605","DOI":"10.1021\/acs.langmuir.1c02260","article-title":"Scratching the surface (modification): developing a quantitative liquid chromatography-tandem mass spectrometry method for the investigation of PEGylated and non-PEGylated lipid mixtures on lipid-coated lanthanide nanoparticles","volume":"37","author":"Arnett","year":"2021","journal-title":"Langmuir"},{"key":"10.1016\/j.jchromb.2026.125260_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119077","article-title":"Quantification of phospholipid degradation products in liposomal pharmaceutical formulations by ultra performance liquid chromatography-mass spectrometry (UPLC-MS)","volume":"578","author":"Siriwardane","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jchromb.2026.125260_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.114287","article-title":"Simultaneous monitoring of multiple attributes of pyrrolobenzodiazepine antibody-drug conjugates by size exclusion chromatography \u2013 high resolution mass spectrometry","volume":"205","author":"F\u00fcssl","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2026.125260_bb0375","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2024.2446304","article-title":"Online native hydrophobic interaction chromatography-mass spectrometry of antibody-drug conjugates","volume":"17","author":"Kempen","year":"2025","journal-title":"MAbs"},{"key":"10.1016\/j.jchromb.2026.125260_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2019.121814","article-title":"A generic method for intact and subunit level characterization of mAb charge variants by native mass spectrometry","volume":"1133","author":"Leblanc","year":"2019","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jchromb.2026.125260_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115337","article-title":"A generic platform to couple affinity chromatography with native mass spectrometry for the analysis of therapeutic monoclonal antibodies","volume":"228","author":"Cotham","year":"2023","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2026.125260_bb0390","first-page":"33","article-title":"Mixed mode chromatographic stationary phases in pharmaceutical peptide analysis","volume":"5","author":"Abbood","year":"2025","journal-title":"Int. J. Adv. Pharm. Sci. Res."},{"key":"10.1016\/j.jchromb.2026.125260_bb0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2025.344852","article-title":"Ion exclusion chromatography of RNA-lipid nanoparticles using polyethyleneimine-modified spongy monoliths","volume":"1383","author":"Drennan","year":"2026","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jchromb.2026.125260_bb0400","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.talanta.2013.03.048","article-title":"Ion suppression; a critical review on causes, evaluation, prevention and applications","volume":"115","author":"Furey","year":"2013","journal-title":"Talanta"},{"key":"10.1016\/j.jchromb.2026.125260_bb0405","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.1021\/ac025988p","article-title":"Effect of signal interference from dosing excipients on pharmacokinetic screening of drug candidates by liquid chromatography\/mass spectrometry","volume":"74","author":"Tong","year":"2002","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jchromb.2026.125260_bb0410","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28052061","article-title":"Advances in ultra-high-resolution mass spectrometry for pharmaceutical analysis","volume":"28","author":"Deschamps","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.jchromb.2026.125260_bb0415","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/ansa.202000149","article-title":"Advances in high-resolution mass spectrometry applied to pharmaceuticals in 2020: a whole new age of information","volume":"2","author":"G\u00e9hin","year":"2021","journal-title":"Anal. Sci. Adv."},{"key":"10.1016\/j.jchromb.2026.125260_bb0420","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1007\/s00216-015-9245-6","article-title":"A study of inter-species ion suppression in electrospray ionization-mass spectrometry of some phospholipid classes","volume":"408","author":"Khoury","year":"2016","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jchromb.2026.125260_bb0425","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1002\/rcm.1071","article-title":"Cone voltage induced in-source dissociation of glucuronides in electrospray and implications in biological analyses","volume":"17","author":"Yan","year":"2003","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.jchromb.2026.125260_bb0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2019.06.063","article-title":"A rational strategy based on experimental designs to optimize parameters of a liquid chromatography-mass spectrometry analysis of complex matrices","volume":"205","author":"Reymond","year":"2019","journal-title":"Talanta"},{"key":"10.1016\/j.jchromb.2026.125260_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2025.124564","article-title":"Evaluation of ion source parameters and liquid chromatography methods for plasma untargeted metabolomics using orbitrap mass spectrometer","volume":"1257","author":"Assress","year":"2025","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jchromb.2026.125260_bb0440","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jconrel.2019.04.039","article-title":"Characterization of branched poly(lactide-co-glycolide) polymers used in injectable, long-acting formulations","volume":"304","author":"Hadar","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jchromb.2026.125260_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2020.122433","article-title":"Systematic development of a bioanalytical UPLC-MS\/MS method for estimation of risperidone and its active metabolite in long-acting microsphere formulation in rat plasma","volume":"1160","author":"Rub","year":"2020","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jchromb.2026.125260_bb0450","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.jpba.2015.05.023","article-title":"Development of a validated LC-APCI-MS\/MS method to study the plasma and tumor distribution of CHO-PTX intravenous lipid emulsion","volume":"117","author":"Xia","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2026.125260_bb0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2025.466606","article-title":"Advances in LC\u2013MS strategies for comprehensive characterization and quantification of antibody-drug conjugates in preclinical and clinical settings","volume":"1766","author":"Kumar","year":"2026","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jchromb.2026.125260_bb0460","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1208\/s12248-025-01169-9","article-title":"New Frontiers in ADC analysis: advances in chromatography, electrophoresis, and mass spectrometry","volume":"28","author":"Beck","year":"2025","journal-title":"AAPS J."},{"key":"10.1016\/j.jchromb.2026.125260_bb0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106502","article-title":"Hybrid liquid chromatography high resolution and accuracy mass spectrometry approach for quantification of antibody-drug conjugates at the intact protein level in biological samples","volume":"188","author":"Barbero","year":"2023","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jchromb.2026.125260_bb0470","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1021\/jasms.2c00022","article-title":"Postcolumn infusion as a quality control tool for LC-MS-based analysis","volume":"33","author":"Gonz\u00e1lez","year":"2022","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.jchromb.2026.125260_bb0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2024.465580","article-title":"Matrix effect evaluation using multi-component post-column infusion in untargeted hydrophilic interaction liquid chromatography-mass spectrometry plasma metabolomics","volume":"1740","author":"Zhu","year":"2025","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jchromb.2026.125260_bb0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2025.466508","article-title":"Matrix effects in untargeted LC-MS metabolomics: from creation to compensation with post-column infusion of standards","volume":"1765","author":"Zhu","year":"2026","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jchromb.2026.125260_bb0485","doi-asserted-by":"crossref","DOI":"10.1002\/sscp.70073","article-title":"A review on applications of liquid chromatography coupled with mass spectrometry in impurity profiling of drug substances and drug products","volume":"8","author":"Rambhad","year":"2025","journal-title":"Sep. Sci. Plus"},{"key":"10.1016\/j.jchromb.2026.125260_bb0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2025.103749","article-title":"Navigating ICH Q2(R2) compliance in analytical method validation: a gap analysis toolkit to streamline risk assessment and change management","volume":"114","author":"Cassidy","year":"2025","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jchromb.2026.125260_bb0495","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1021\/acs.analchem.4c04521","article-title":"A modern framework for analytical procedure development and lifecycle management based on ICH Q14 principles","volume":"97","author":"Eberle","year":"2025","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jchromb.2026.125260_bb0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2025.116884","article-title":"A convenient and rapid LC-MS\/MS method for determination of free and liposomal amphotericin B in human plasma by simultaneous separation using SPE","volume":"262","author":"Jin","year":"2025","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2026.125260_bb0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2025.124751","article-title":"Analysis of lipid nanoparticles using two-dimensional chromatography: simultaneous determination of encapsulation efficiency, nucleic acid integrity, and size of LNP formulations","volume":"1265","author":"Pavlin","year":"2025","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jchromb.2026.125260_bb0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2023.464375","article-title":"Optimization of HPLCCAD method for simultaneous analysis of different lipids in lipid nanoparticles with analytical QbD","volume":"1709","author":"Kim","year":"2023","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jchromb.2026.125260_bb0515","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/elps.202100244","article-title":"Determination of lipid content and stability in lipid nanoparticles using ultra high-performance liquid chromatography in combination with a Corona charged aerosol detector","volume":"43","author":"Kinsey","year":"2022","journal-title":"Electrophoresis"},{"key":"10.1016\/j.jchromb.2026.125260_bb0520","series-title":"International conference on harmonisation, analytical procedure development Q14","year":"2022"},{"key":"10.1016\/j.jchromb.2026.125260_bb0525","series-title":"International conference on harmonisation, bioanalytical method validation and study sample analysis M10","year":"2022"},{"key":"10.1016\/j.jchromb.2026.125260_bb0530","doi-asserted-by":"crossref","DOI":"10.1002\/sscp.70031","article-title":"Identification and structural elucidation of a potential citric acid and caprolactam adduct impurity in aminocaproic acid injection using preparative chromatography, LC\u2013MS, and NMR","volume":"8","author":"Mukkapati","year":"2025","journal-title":"Sep. Sci. Plus"},{"key":"10.1016\/j.jchromb.2026.125260_bb0535","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jpba.2013.04.027","article-title":"Critical practical aspects in the application of liquid chromatography-mass spectrometric studies for the characterization of impurities and degradation products","volume":"87","author":"Narayanam","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2026.125260_bb0540","doi-asserted-by":"crossref","DOI":"10.3390\/chemosensors11050294","article-title":"Identification of degradation products of the new anticancer drug substance ONC201 by liquid chromatography\u2013high-resolution multistage mass spectrometry","volume":"11","author":"Annereau","year":"2023","journal-title":"Chemosensors"},{"key":"10.1016\/j.jchromb.2026.125260_bb0545","doi-asserted-by":"crossref","DOI":"10.1038\/s42004-025-01699-5","article-title":"Spotlighting the criticality of lipid quality control through a mechanistic investigation of mRNA activity loss in lipid nanoparticles","volume":"8","author":"Kang","year":"2025","journal-title":"Commun. Chem."},{"key":"10.1016\/j.jchromb.2026.125260_bb0550","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1007\/s00216-026-06513-2","article-title":"Direct LC\u2013HRMS\/MS characterisation and RT\u2013qPCR detection for potential mRNA-based doping agent","volume":"418","author":"Yuen","year":"2026","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jchromb.2026.125260_bb0555","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/jbm.b.33920","article-title":"Mapping intermediate degradation products of poly(lactic-co-glycolic acid) in vitro","volume":"106","author":"Li","year":"2018","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"10.1016\/j.jchromb.2026.125260_bb0560","doi-asserted-by":"crossref","DOI":"10.1186\/s40543-024-00437-1","article-title":"Advances in mass spectrometry-based approaches for characterizing monoclonal antibodies: resolving structural complexity and analytical challenges","volume":"15","author":"Mojumdar","year":"2024","journal-title":"J. Anal. Sci. Technol."},{"key":"10.1016\/j.jchromb.2026.125260_bb0565","series-title":"Experientia supplementum","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-030-76912-3_1","article-title":"Micro-heterogeneity of antibody molecules","author":"Mimura","year":"2021"},{"key":"10.1016\/j.jchromb.2026.125260_bb0570","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113169","article-title":"Mass spectrometry-based methods in characterization of the higher order structure of protein therapeutics","volume":"184","author":"Kaltashov","year":"2020","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2026.125260_bb0575","doi-asserted-by":"crossref","first-page":"8136","DOI":"10.1021\/acs.analchem.1c04450","article-title":"mD-UPLC-MS\/MS: next generation of mAb characterization by multidimensional ultraperformance liquid chromatography-mass spectrometry and parallel on-column LysC and trypsin digestion","volume":"94","author":"Oezipek","year":"2022","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jchromb.2026.125260_bb0580","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2024.116331","article-title":"A combination of multiple LC-MS approaches for the comprehensive characterization of cysteine-linked ADCs","volume":"248","author":"Wu","year":"2024","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2026.125260_bb0585","series-title":"Bioanalysis of biological matrix samples using liquid chromatography-tandem mass spectrometry detection, specification of drug substances and products: development and validation of analytical methods","first-page":"843","author":"Wang","year":"2025"},{"key":"10.1016\/j.jchromb.2026.125260_bb0590","first-page":"91","article-title":"LC-MS method for studying the pharmacokinetics and bioequivalence of clonidine hydrochloride in healthy male volunteers","volume":"8","author":"Danafar","year":"2016","journal-title":"Avicenna J. Med. Biotechnol"},{"key":"10.1016\/j.jchromb.2026.125260_bb0595","doi-asserted-by":"crossref","first-page":"27728","DOI":"10.1038\/s41598-025-13396-3","article-title":"LC-MS\/MS quantification of omadacycline in human plasma for therapeutic drug monitoring: method development and clinical application","volume":"15","author":"Wang","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jchromb.2026.125260_bb0600","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/FTD.0000000000000558","article-title":"An LC-MS\/MS method for absolute quantification of Nivolumab in human plasma: application to clinical therapeutic drug monitoring","volume":"40","author":"Irie","year":"2018","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jchromb.2026.125260_bb0605","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3390\/separations8020021","article-title":"ESI\u2013LC\u2013MS\/MS for therapeutic drug monitoring of binary mixture of Pregabalin and tramadol: human plasma and urine applications","volume":"8","author":"Almalki","year":"2021","journal-title":"Separations"},{"key":"10.1016\/j.jchromb.2026.125260_bb0610","doi-asserted-by":"crossref","first-page":"1116071","DOI":"10.3389\/fphar.2023.1116071","article-title":"LC-MS\/MS-based multiplex antibacterial platform for therapeutic drug monitoring in intensive care unit patients","volume":"14","author":"Liu","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jchromb.2026.125260_bb0615","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/FTD.0000000000000570","article-title":"Simultaneous quantification of nine antimicrobials by LC-MS\/MS for therapeutic drug monitoring in critically ill patients","volume":"41","author":"Neugebauer","year":"2019","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jchromb.2026.125260_bb0620","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27196190","article-title":"Development of UPLC-MS\/MS method to study the pharmacokinetic interaction between sorafenib and dapagliflozin in rats","volume":"27","author":"He","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.jchromb.2026.125260_bb0625","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.5924","article-title":"Assessment of drug-drug interaction of dapagliflozin with LCZ696 based on an LC-MS\/MS method","volume":"38","author":"Wang","year":"2024","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jchromb.2026.125260_bb0630","doi-asserted-by":"crossref","first-page":"9565","DOI":"10.1039\/D5AY01451D","article-title":"LC-MS\/MS-based investigation of pharmacokinetic interactions between CYP3A4 substrates enzalutamide and repaglinide in rats","volume":"17","author":"Navitha Reddy","year":"2025","journal-title":"Anal. Methods"},{"key":"10.1016\/j.jchromb.2026.125260_bb0635","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2025.116770","article-title":"Development and validation of an LC-MS\/MS method for pharmacokinetic assessment of a bispecific antibody (YBSW015) targeting SARS-CoV-2","volume":"260","author":"Chai","year":"2025","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2026.125260_bb0640","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.4155\/bio.14.142","article-title":"A multiplexed hybrid LC-MS\/MS pharmacokinetic assay to measure two co-administered monoclonal antibodies in a clinical study","volume":"6","author":"Xu","year":"2014","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jchromb.2026.125260_bb0645","doi-asserted-by":"crossref","first-page":"165","DOI":"10.4155\/bio-2023-0261","article-title":"Immunocapture LC-MS methods for pharmacokinetics of large molecule drugs","volume":"16","author":"Werth","year":"2024","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jchromb.2026.125260_bb0650","doi-asserted-by":"crossref","first-page":"13874","DOI":"10.1021\/acs.analchem.9b03367","article-title":"Bioanalysis of targeted nanoparticles in monkey plasma via LC-MS\/MS","volume":"91","author":"Song","year":"2019","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jchromb.2026.125260_bb0655","doi-asserted-by":"crossref","DOI":"10.1016\/j.dmd.2025.100081","article-title":"Integrated strategy for biotransformation of antibody\u2013drug conjugates and multidimensional interpretation via high-resolution mass spectrometry","volume":"53","author":"Li","year":"2025","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jchromb.2026.125260_bb0660","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1021\/acsptsci.4c00445","article-title":"Detailed structural elucidation of antibody-drug conjugate biotransformation species using high resolution multiple reaction monitoring mass spectrometry with orthogonal dissociation methods","volume":"8","author":"Yang","year":"2025","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.jchromb.2026.125260_bb0665","doi-asserted-by":"crossref","first-page":"16525","DOI":"10.1021\/acs.analchem.4c02309","article-title":"Extensive biotransformation profiling of AZD8205, an anti-B7-H4 antibody-drug conjugate, elucidates pathways underlying its stability in vivo","volume":"96","author":"Huang","year":"2024","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jchromb.2026.125260_bb0670","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1124\/dmd.122.001135","article-title":"Detection and characterization of in vitro payload-containing catabolites of noncleavable antibody-drug conjugates by high-resolution mass spectrometry and multiple data mining tools","volume":"51","author":"Cai","year":"2023","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jchromb.2026.125260_bb0675","doi-asserted-by":"crossref","first-page":"5919","DOI":"10.1021\/acs.analchem.4c04311","article-title":"Streamlined high-throughput data analysis workflow for antibody-drug conjugate biotransformation characterization","volume":"97","author":"Liu","year":"2025","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jchromb.2026.125260_bb0680","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1016\/j.xphs.2019.06.009","article-title":"Identification of an adduct impurity of an active pharmaceutical ingredient and a leachable in an ophthalmic drug product using LC-QTOF","volume":"108","author":"Gollapalli","year":"2019","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jchromb.2026.125260_bb0685","article-title":"An innovative impurity profiling of esmolol hydrochloride injection using UPLC-MS based multiple mass defect filter, chemometrics and in-silico toxicity prediction","volume":"16","author":"Zhang","year":"2023","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.jchromb.2026.125260_bb0690","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.114099","article-title":"Impurity profiling of compound amino acid injection (6AA) using ion-pair high performance liquid chromatography coupled with corona-charged aerosol detection and high resolution mass spectrometry","volume":"201","author":"Qiu","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2026.125260_bb0695","doi-asserted-by":"crossref","first-page":"312","DOI":"10.4103\/1735-5362.293509","article-title":"LC-MS based stability-indicating method for studying the degradation of lonidamine under physical and chemical stress conditions","volume":"15","author":"Rochani","year":"2020","journal-title":"Res. Pharm. Sci."},{"key":"10.1016\/j.jchromb.2026.125260_bb0700","doi-asserted-by":"crossref","first-page":"748","DOI":"10.64252\/kr45v086","article-title":"Advanced LC-MS\/MS-based impurity profiling and forced degradation characterization of sulfamethoxazole and clindamycin in combined pharmaceutical formulations","author":"Shareef","year":"2025","journal-title":"Int. J. Environ. Sci."},{"key":"10.1016\/j.jchromb.2026.125260_bb0705","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2025.465769","article-title":"Comparative analysis of impurity profiles in rifampicin capsules with different crystal forms using LC-MS\/MS","volume":"1746","author":"Shen","year":"2025","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jchromb.2026.125260_bb0710","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.114753","article-title":"Degradation kinetics and characterization of major degradants of binimetinib employing liquid chromatography-high resolution mass spectrometry","volume":"215","author":"Rajput","year":"2022","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2026.125260_bb0715","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2026.117633","article-title":"Analyzing the impact of ionizable lipid identity, purity, and stability on lipid nanoparticle performance","volume":"281","author":"Rubio-Prego","year":"2026","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2026.125260_bb0720","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/rcm.7926","article-title":"Rapid and simple flow injection analysis tandem mass spectrometric method for the quantification of melphalan in a lipid-based drug delivery system","volume":"31","author":"Mohammed-Saeid","year":"2017","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.jchromb.2026.125260_bb0725","doi-asserted-by":"crossref","first-page":"S1226","DOI":"10.1080\/21691401.2018.1536063","article-title":"Synergistic co-delivery of doxorubicin and melittin using functionalized magnetic nanoparticles for cancer treatment: loading and in vitro release study by LC-MS\/MS","volume":"46","author":"Hematyar","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.jchromb.2026.125260_bb0730","doi-asserted-by":"crossref","first-page":"11868","DOI":"10.1038\/s41598-025-96764-3","article-title":"Development and validation of an LC-MS\/MS method for quantitative determination of LXT-101 sustained-release suspension, a novel drug in treating prostate cancer, in beagle plasma","volume":"15","author":"Li","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jchromb.2026.125260_bb0735","first-page":"4521","article-title":"Development of PLGA-based itraconazole injectable nanospheres for sustained release","volume":"8","author":"Bian","year":"2013","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jchromb.2026.125260_bb0740","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jconrel.2024.11.021","article-title":"In vitro-in vivo correlation (IVIVC) development for long-acting injectable drug products based on poly(lactide-co-glycolide)","volume":"377","author":"Wang","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jchromb.2026.125260_bb0745","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1208\/s12249-015-0366-1","article-title":"Development, optimization, and characterization of PEGylated Nanoemulsion of prostaglandin E1 for Long circulation","volume":"17","author":"Cheng","year":"2016","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jchromb.2026.125260_bb0750","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.4409","article-title":"Fanaras, use of high-pH (basic\/alkaline) mobile phases for LC-MS or LC-MS\/MS bioanalysis","volume":"33","author":"Tan","year":"2019","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jchromb.2026.125260_bb0755","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27030907","article-title":"Recent developments of liquid chromatography stationary phases for compound separation: from proteins to small organic compounds","volume":"27","author":"Rusli","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.jchromb.2026.125260_bb0760","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s43586-022-00175-x","article-title":"Liquid chromatography-tandem mass spectrometry for clinical diagnostics","volume":"2","author":"Thomas","year":"2022","journal-title":"Nat. Rev. Methods Primers"},{"key":"10.1016\/j.jchromb.2026.125260_bb0765","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.cll.2018.05.003","article-title":"Special considerations for liquid chromatography-tandem mass spectrometry method development","volume":"38","author":"Rappold","year":"2018","journal-title":"Clin. Lab. Med."},{"key":"10.1016\/j.jchromb.2026.125260_bb0770","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jpha.2022.03.001","article-title":"Current developments of bioanalytical sample preparation techniques in pharmaceuticals","volume":"12","author":"Ingle","year":"2022","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.jchromb.2026.125260_bb0775","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16020266","article-title":"The development of a stable peptide-loaded long-acting injection formulation through a comprehensive understanding of peptide degradation mechanisms: a QbD-based approach","volume":"16","author":"Xiong","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jchromb.2026.125260_bb0780","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jpba.2015.07.041","article-title":"An ultrasensitive LC-MS\/MS method with liquid phase extraction to determine paclitaxel in both cell culture medium and lysate promising quantification of drug nanocarriers release in vitro","volume":"115","author":"Baati","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2026.125260_bb0785","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1586\/14789450.2015.1024225","article-title":"Strategies for improving sensitivity and selectivity for the quantitation of biotherapeutics in biological matrix using LC-MS\/MS","volume":"12","author":"Shen","year":"2015","journal-title":"Expert Rev. Proteom."},{"key":"10.1016\/j.jchromb.2026.125260_bb0790","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.3390\/molecules25133047","article-title":"Compensate for or minimize matrix effects? Strategies for overcoming matrix effects in liquid chromatography-mass spectrometry technique: a tutorial review","volume":"25","author":"Cortese","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.jchromb.2026.125260_bb0795","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2022.107464","article-title":"Critical strategies to pinpoint carryover problems in liquid chromatography-mass spectrometry: a systematic direction for their origin identification and mitigation","volume":"179","author":"Jogpethe","year":"2022","journal-title":"Microchem. J."},{"key":"10.1016\/j.jchromb.2026.125260_bb0800","doi-asserted-by":"crossref","first-page":"9322","DOI":"10.1038\/s41598-022-13389-6","article-title":"Multiple-reaction monitoring (MRM) LC-MS\/MS quantitation of venlafaxine and its O-desmethyl metabolite for a preclinical pharmacokinetic study in rabbits","volume":"12","author":"Fazli","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jchromb.2026.125260_bb0805","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1007\/s00216-021-03829-z","article-title":"Enhancement of sensitivity and quantification quality in the LC-MS\/MS measurement of large biomolecules with sum of MRM (SMRM)","volume":"414","author":"Tang","year":"2022","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jchromb.2026.125260_bb0810","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1007\/s00216-021-03831-5","article-title":"Coupling immuno-magnetic capture with LC-MS\/MS(MRM) as a sensitive, reliable, and specific assay for SARS-CoV-2 identification from clinical samples","volume":"414","author":"Schuster","year":"2022","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jchromb.2026.125260_bb0815","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.114473","article-title":"Analysis of verteporfin liposomal formulations for phospholipids and phospholipid degradation products by liquid chromatography-mass spectrometry (LC-MS)","volume":"208","author":"Ansar","year":"2022","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2026.125260_bb0820","doi-asserted-by":"crossref","first-page":"11018","DOI":"10.1038\/s41598-024-61522-4","article-title":"A simple and highly sensitive LC-MS workflow for characterization and quantification of ADC cleavable payloads","volume":"14","author":"Mak","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jchromb.2026.125260_bb0825","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.jpba.2015.07.012","article-title":"Quantitative LC-MS determination of liposomal encapsulated prednisolone phosphate and non-encapsulated prednisolone concentrations in murine whole blood and liver tissue","volume":"115","author":"Smits","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2026.125260_bb0830","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1021\/acs.analchem.9b05036","article-title":"Implementation of a high-resolution liquid chromatography-mass spectrometry method in quality control laboratories for release and stability testing of a commercial antibody product","volume":"92","author":"Sokolowska","year":"2020","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jchromb.2026.125260_bb0835","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2025.124751","article-title":"Analysis of lipid nanoparticles using two-dimensional chromatography: simultaneous determination of encapsulation efficiency, nucleic acid integrity, and size of LNP formulations","volume":"1265","author":"Pavlin","year":"2025","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jchromb.2026.125260_bb0840","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1208\/s12248-023-00835-0","article-title":"Enhanced pharmacokinetic bioanalysis of antibody-drug conjugates using hybrid immunoaffinity capture and microflow LC-MS\/MS","volume":"25","author":"Suh","year":"2023","journal-title":"AAPS J."},{"key":"10.1016\/j.jchromb.2026.125260_bb0845","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2024.116484","article-title":"Comparison of analytical-flow, micro-flow and nano-flow LC-MS\/MS for sub-proteome analysis","volume":"252","author":"Long","year":"2025","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2026.125260_bb0850","article-title":"Green LC-MS\/MS method for in-vivo pharmacokinetics of mirabegron-encapsulated nanostructured lipid carriers in rat plasma: integrating white analytical chemistry and analytical quality by design approach","volume":"39","author":"Prajapati","year":"2024","journal-title":"Sustain. Chem. Pharm."},{"key":"10.1016\/j.jchromb.2026.125260_bb0855","doi-asserted-by":"crossref","DOI":"10.1016\/j.talo.2025.100476","article-title":"A novel and green UFLC-MS\/MS method for quantification of amantadine and levodopa in polymeric nanoparticles: application to determine drug loading (%DL), drug entrapment (%DEE) and drug release profile","volume":"12","author":"Lahiri","year":"2025","journal-title":"Talanta Open"},{"key":"10.1016\/j.jchromb.2026.125260_bb0860","series-title":"Direct analysis in real time mass spectrometry","first-page":"241","article-title":"DART-MS applications in pharmaceuticals. In Direct analysis in real time mass spectrometry","author":"Putri","year":"2018"},{"key":"10.1016\/j.jchromb.2026.125260_bb0865","doi-asserted-by":"crossref","first-page":"7184","DOI":"10.1021\/acsnano.5c20618","article-title":"Collagenase-functionalized liposomes overcome stromal barriers in pancreatic Cancer","volume":"20","author":"Hwang","year":"2026","journal-title":"ACS Nano"},{"key":"10.1016\/j.jchromb.2026.125260_bb0870","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.stem.2026.01.001","article-title":"Lipid nanoparticle-based non-viral in situ gene editing of congenital ichthyosis-causing mutations in human skin models","volume":"33","author":"Apaydin","year":"2026","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jchromb.2026.125260_bb0875","doi-asserted-by":"crossref","DOI":"10.1038\/s42004-023-00818-4","article-title":"Release of nanodiscs from charged nano-droplets in the electrospray ionization revealed by molecular dynamics simulations","volume":"6","author":"Wang","year":"2023","journal-title":"Commun. Chem."},{"key":"10.1016\/j.jchromb.2026.125260_bb0880","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1007\/s00216-024-05227-7","article-title":"Online electrochemistry coupling liquid chromatography-mass spectrometry for rapid investigation on the phase I and phase II simulated metabolic reactions of flavonoids","volume":"416","author":"Niu","year":"2024","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jchromb.2026.125260_bb0885","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1021\/acs.chemrev.2c00600","article-title":"Ion mobility mass spectrometry (IM-MS) for structural biology: insights gained by measuring mass, charge, and collision cross section","volume":"123","author":"Christofi","year":"2023","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jchromb.2026.125260_bb0890","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/mas.21902","article-title":"Recent advances in high-resolution traveling wave-based ion mobility separations coupled to mass spectrometry","volume":"44","author":"Naylor","year":"2025","journal-title":"Mass Spectrom. Rev."},{"key":"10.1016\/j.jchromb.2026.125260_bb0895","doi-asserted-by":"crossref","first-page":"31885","DOI":"10.1021\/jacs.4c11066","article-title":"Ion mobility-mass spectrometry captures the structural consequences of lipid nanoparticle encapsulation on ribonucleic acid cargo","volume":"146","author":"Anders","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jchromb.2026.125260_bb0900","doi-asserted-by":"crossref","first-page":"18984","DOI":"10.1039\/D5RA08835F","article-title":"Gauging lipid vulnerabilities in mRNA-LNPs under various environmental stressors through TIMS-TOF analysis","volume":"16","author":"Girgis","year":"2026","journal-title":"RSC Adv."},{"key":"10.1016\/j.jchromb.2026.125260_bb0905","doi-asserted-by":"crossref","first-page":"5021","DOI":"10.1021\/acs.analchem.8b04979","article-title":"Effective liquid chromatography-trapped ion mobility spectrometry-mass spectrometry separation of isomeric lipid species","volume":"91","author":"Fouque","year":"2019","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jchromb.2026.125260_bb0910","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1208\/s12248-025-01115-9","article-title":"Recent advances in bioanalytical methods for quantification and pharmacokinetic analyses of antibody-drug conjugates","volume":"27","author":"Khan","year":"2025","journal-title":"AAPS J."},{"key":"10.1016\/j.jchromb.2026.125260_bb0915","doi-asserted-by":"crossref","first-page":"15656","DOI":"10.1021\/acs.analchem.3c02856","article-title":"Parallelized acquisition of orbitrap and astral analyzers enables high-throughput quantitative analysis","volume":"95","author":"Stewart","year":"2023","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jchromb.2026.125260_bb0920","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1021\/jasms.5c00321","article-title":"A novel compact multi-reflecting time-of-flight mass spectrometer","volume":"37","author":"Verenchikov","year":"2026","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.jchromb.2026.125260_bb0925","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jproteome.5c01278","article-title":"DIA-NN EasyFilter workflow for the fast and user-friendly critical assessment and visualization of DIA-NN proteomics analysis outcome","author":"Moagi","year":"2026","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.jchromb.2026.125260_bb0930","series-title":"Characterizing and monitoring impurities in lipid nanoparticle components using the bioaccord\u2122 LC-MS system with waters_connect\u2122 software","author":"DeLaney","year":"2023"},{"key":"10.1016\/j.jchromb.2026.125260_bb0935","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26073080","article-title":"Unlocking the complexity of antibody-drug conjugates: a cutting-edge LC-HRMS approach to refine drug-to-antibody ratio measurements with highly reactive payloads","volume":"26","author":"Di Ianni","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jchromb.2026.125260_bb0940","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.tibtech.2023.08.008","article-title":"What should next-generation analytical platforms for biopharmaceutical production look like?","volume":"42","author":"Rathore","year":"2024","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.jchromb.2026.125260_bb0945","first-page":"159","article-title":"Application of a novel LC\u2013MS-based proteomic workflow for host cell protein monitoring and risk control in biotherapeutics","volume":"9","author":"Yu","year":"2026","journal-title":"Antib. Ther."},{"key":"10.1016\/j.jchromb.2026.125260_bb0950","first-page":"2454","article-title":"Enhancing automated drug substance impurity structure elucidation from tandem mass spectra through transfer learning and domain knowledge, digital","volume":"4","author":"Dorigatti","year":"2025","journal-title":"Discovery"},{"key":"10.1016\/j.jchromb.2026.125260_bb0955","series-title":"International conference on harmonisation, validation of analytical procedures Q2(R2)","year":"2022"},{"key":"10.1016\/j.jchromb.2026.125260_bb0960","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s40259-022-00518-w","article-title":"Bioanalytical methods and strategic perspectives addressing the rising complexity of novel bioconjugates and delivery routes for biotherapeutics","volume":"36","author":"Mu","year":"2022","journal-title":"BioDrugs"},{"key":"10.1016\/j.jchromb.2026.125260_bb0965","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2025.116964","article-title":"LBA and LC-MS\/MS based comprehensive bioanalytical methods for FDA018, a Trop-2 targeted antibody-drug conjugate","volume":"264","author":"Cheng","year":"2025","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2026.125260_bb0970","series-title":"GSK provides an update on Blenrep (belantamab mafodotin-blmf) US marketing authorisation","author":"GSK","year":"2022"}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023226003491?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023226003491?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:16:50Z","timestamp":1788481010000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023226003491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":194,"alternative-id":["S1570023226003491"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2026.125260","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analytical strategies for complex injectables: the expanding role of LC-MS technologies","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2026.125260","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"125260"}}